Research | Medication First

Medication First treatment throughout the healthcare system

We aim to support only the best scientific approaches to the opioid epidemic. Below are articles related to buprenorphine treatment with a focus on primary care and other non-traditional treatment settings. Please email any articles you would like us to consider to: science@medicationfirst.org.

MORTALITY PREVENTION

Sordo, Luis, et al. "Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies." bmj 357 (2017): j1550.

Schwartz, Robert P., et al. "Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995–2009." American journal of public health 103.5 (2013): 917-922.

Auriacombe, Marc, et al. "French field experience with buprenorphine." The American Journal on Addictions 13.S1 (2004).

Carrieri, Maria Patrizia, et al. "Buprenorphine use: the international experience." Clinical Infectious Diseases43.Supplement_4 (2006): S197-S215.

LOW THRESHOLD TREATMENT

Bhatraju, Elenore Patterson, et al. "Public sector low threshold office-based buprenorphine treatment: outcomes at year 7." Addiction science & clinical practice 12.1 (2017): 7.

Sigmon, Stacey C., et al. "Interim buprenorphine vs. waiting list for opioid dependence." New England Journal of Medicine 375.25 (2016): 2504-2505.

EMERGENCY DEPARTMENT INDUCTION

D’Onofrio, Gail, et al. "Emergency department–initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial." Jama 313.16 (2015): 1636-1644.